Drug profile · INN
meningococcal groups a, c, w, y conjugate and group b vaccine (recombinant, adsorbed)
PENBRAYA
meningococcal groups a, c, w, y conjugate and group b vaccine (recombinant, adsorbed) (PENBRAYA) is an FDA-listed pharmaceutical active ingredient.
EMA: withdrawn Antiinfectives for systemic use (J07) J07AH11
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — meningococcal groups a, c, w, y conjugate and group b vaccine (recombinant, adsorbed)
- Class
- Antiinfectives for systemic use (J07)
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.83
Quick answer
meningococcal groups a, c, w, y conjugate and group b vaccine (recombinant, adsorbed) (PENBRAYA) is an FDA-listed pharmaceutical active ingredient.
Key facts
INN meningococcal groups a, c, w, y conjugate and group b vaccine (recombinant, adsorbed)
Brand PENBRAYA
Therapeutic class Antiinfectives for systemic use (J07)
ATC code J07AH11
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | withdrawn | — |
Related & competitor drugs
Frequently asked questions
What is meningococcal groups a, c, w, y conjugate and group b vaccine (recombinant, adsorbed)?
meningococcal groups a, c, w, y conjugate and group b vaccine (recombinant, adsorbed) (PENBRAYA) is an FDA-listed pharmaceutical active ingredient.
What is the brand name for meningococcal groups a, c, w, y conjugate and group b vaccine (recombinant, adsorbed)?
PENBRAYA is a marketed brand name for meningococcal groups a, c, w, y conjugate and group b vaccine (recombinant, adsorbed). Check FDA Drugs@FDA for the current US label holder and prescribing information.